LYME DISEASE

This study tested a new vaccine (VLA15) to prevent Lyme disease, a tick-borne illness. About 12,500 healthy people aged 5 and older in high-risk areas received either the vaccine or a placebo. Researchers tracked how many got Lyme disease to see if the vaccine works and is safe.

This study tested whether a new Lyme disease vaccine (VLA15) is safe for healthy children ages 5 to 17. Over 3,500 children received either the vaccine or a placebo (saltwater shot) and were monitored for about 2 years. The goal was to see if the vaccine causes any side effects l…

This study tested two new mRNA vaccine candidates designed to prevent Lyme disease. It involved 807 healthy adults to see if the vaccines were safe and if they triggered a good immune response against the bacteria that causes Lyme. The study compared different doses of the vaccin…

This study tested whether a short, in-class educational program could help children aged 7 to 12 living in areas with high Lyme disease rates learn how to protect themselves. The program taught kids about personal protective practices, early disease detection, and reducing tick h…

This study tested a special method called xenodiagnosis to see if Lyme disease bacteria can survive after antibiotic treatment. Researchers placed disease-free ticks on the skin of 45 adults with different stages of Lyme disease, as well as healthy volunteers. The goal was to see…